Theravance Biopharma, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Theravance Biopharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q2 2024.
  • Theravance Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.38M, a 14.2% decline year-over-year.
  • Theravance Biopharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $22.7M, a 21.1% decline year-over-year.
  • Theravance Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $25.4M, a 36.1% decline from 2022.
  • Theravance Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $39.7M, a 36% decline from 2021.
  • Theravance Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $62.1M, a 1.45% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $22.7M $5.38M -$888K -14.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $23.6M $5.23M -$1.79M -25.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $25.4M $5.82M -$1.13M -16.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-01
Q3 2023 $26.5M $6.26M -$2.27M -26.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $28.8M $6.26M -$3.45M -35.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $32.2M $7.02M -$7.52M -51.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $39.7M $6.95M -$9.97M -58.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-01
Q3 2022 $49.7M $8.53M -$5.84M -40.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $55.5M $9.71M -$5.23M -35% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $60.8M $14.5M -$1.29M -8.13% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $62.1M $16.9M +$1.37M +8.79% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 $60.7M $14.4M -$1.19M -7.67% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $61.9M $14.9M -$1.64M -9.91% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $63.5M $15.8M +$556K +3.64% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $63M $15.6M -$8.36M -35% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $71.3M $15.6M +$2.55M +19.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $68.8M $16.6M +$5.29M +46.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $63.5M $15.3M +$3.06M +25% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $60.5M $23.9M +$12.2M +104% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $48.3M $13M +$1.27M +10.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $47M $11.3M -$2.56M -18.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $49.5M $12.2M -$1.78M -12.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $51.3M $11.7M -$6.08M -34.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $57.4M $11.7M +$1.06M +9.93% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $56.3M $13.9M +$3.46M +33.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $52.9M $14M +$3.73M +36.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $49.1M $17.8M +$7.75M +77.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $41.4M $10.7M +$790K +7.98% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $40.6M $10.4M +$494K +4.99% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $40.1M $10.3M -$1.06M -9.37% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $41.2M $10M -$1.47M -12.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $42.6M $9.9M -$2.36M -19.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $45M $9.9M -$4.76M -32.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $49.8M $11.3M -$4.3M -27.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $54.1M $11.5M -$2.91M -20.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $57M $12.3M +$2.9M +31% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $54.1M $14.7M +$7.9M +117% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $46.2M $15.6M +$2.93M +23% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $43.2M $14.4M +$9.26M +179% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $34M $9.35M +$3.76M +67.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $30.2M $6.76M +$557K +8.97% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $29.7M $12.7M +$7.19M +130% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 $22.5M $5.16M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-11
Q3 2013 $5.59M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $6.21M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $5.52M Jan 1, 2013 Mar 31, 2013 10-Q 2014-06-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.